View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board o...

Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors SAN DIEGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced the appointment of Elaine Sorg to its Board of Directors. Ms. Sorg brings more than 35 years of executive leadership and commercial experience in the biopharmaceutical industry to Artiva, including leading the commercialization of major immunology th...

HCA Healthcare Inc: 2 directors

Two Directors at HCA Healthcare Inc sold/sold after exercising options 12,020 shares at between 505.000USD and 514.582USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by al...

 PRESS RELEASE

The Ensign Group Reports Fiscal Year and Fourth Quarter 2025 Results; ...

The Ensign Group Reports Fiscal Year and Fourth Quarter 2025 Results; Issues 2026 Annual Earnings and Revenue Guidance Conference Call and Webcast scheduled for tomorrow, February 5, 2026 at 10:00 am PT SAN JUAN CAPISTRANO, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, primarily in skilled nursing and senior living facilities, announced operating results for the fiscal year and fourth quarter of 2025, re...

 PRESS RELEASE

The Ensign Group Grows Operations in Arizona

The Ensign Group Grows Operations in Arizona SAN JUAN CAPISTRANO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of “Agave Grove Post Acute”, a 225-bed skilled nursing facility located in Glendale, Arizona which is subject to a long-term, triple net lease with a third-party land...

 PRESS RELEASE

The Ensign Group Buys Real Estate and Operations in Wisconsin

The Ensign Group Buys Real Estate and Operations in Wisconsin SAN JUAN CAPISTRANO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of “Timber Ridge Health and Rehabilitation”, a 48-bed skilled nursing facility located in Stevens Point, Wisconsin. The real estate w...

 PRESS RELEASE

The Ensign Group Obtains Real Estate and Operations in Texas

The Ensign Group Obtains Real Estate and Operations in Texas SAN JUAN CAPISTRANO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of “Sunset Valley Rehabilitation and Healthcare Center” an 80-bed skilled nursing facility located in Littlefield, Texas. The real es...

 PRESS RELEASE

The Ensign Group Adds Real Estate and Operations in Texas

The Ensign Group Adds Real Estate and Operations in Texas SAN JUAN CAPISTRANO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of “Wylie Oaks Healthcare and Rehabilitation”, a 106-bed skilled nursing facility located in Wylie, Texas. The real estate was acquired b...

 PRESS RELEASE

The Ensign Group Acquires Real Estate and Operations in Texas

The Ensign Group Acquires Real Estate and Operations in Texas SAN JUAN CAPISTRANO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of “The Chateau Waco”, a 123-bed skilled nursing facility located in Waco, Texas. The real estate was acquired by a subsidiary of St...

 PRESS RELEASE

The Ensign Group Schedules Year End 2025 Earnings Call for Thursday, F...

The Ensign Group Schedules Year End 2025 Earnings Call for Thursday, February 5, 2026 SAN JUAN CAPISTRANO, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it expects to issue its fourth quarter and fiscal year 2025 financial results on Wednesday, February 4, 2026. Conference Call Ensign invites current ...

 PRESS RELEASE

Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Tr...

Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability of AlloNK in NHL SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced presentations at the 2026 Transplantation & Cellular Therap...

Wedbush Research
  • Wedbush Research
 PRESS RELEASE

The Ensign Group, Inc. Increases Quarterly Dividend to $0.0650 Per Sha...

The Ensign Group, Inc. Increases Quarterly Dividend to $0.0650 Per Share SAN JUAN CAPISTRANO, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it has declared a quarterly cash dividend of $0.0650 per share of Ensign common stock, payable on or before January 31, 2026, to shareholders of record as of Decembe...

National Healthcare Corp: 2 directors

Two Directors at National Healthcare Corp sold/gave away 3,454 shares at between 0.000USD and 139.420USD. The significance rating of the trade was 82/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's d...

Tenet Healthcare Corp: 1 director

A director at Tenet Healthcare Corp sold 2,178 shares at 197.470USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

Ensign Group Inc: 1 director

A director at Ensign Group Inc sold after exercising options/sold 8,400 shares at 175.476USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch